Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers

Yanmei Hu, Raymond Kin Hau, Yuanxiang Wang, Peter Tuohy, Yongtao Zhang, Shuting Xu, Chunlong Ma, Jun Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Majority of current circulating influenza A viruses carry the S31N mutation in their M2 genes, rendering AM2-S31N as a high profile antiviral drug target. With our continuous interest in developing AM2-S31N channel blockers as novel antivirals targeting both oseltamivir-sensitive and -resistant influenza A viruses, we report herein the structure-property relationship studies of AM2-S31N inhibitors. The goal was to identify lead compounds with improved microsomal stability and membrane permeability. Two lead compounds, 10d and 10e, were found to have high mouse and human liver microsomal stability (T1/2 > 145 min) and membrane permeability (>200 nm/s). Both compounds also inhibit both currently circulating oseltamivir-sensitive and -resistant human influenza A viruses (H1N1 and H3N2) with EC50 values ranging from 0.4 to 2.8 μM and a selectivity index of >100. We also showed for the first time that AM2-S31N channel blockers such as 10e inhibited influenza virus replication at both low and high multiply of infection (102-106 pfu/mL) and the inhibition was not cell-type dependent. Overall, these studies have identified two promising lead candidates for further development as antiviral drugs against drug-resistant influenza A viruses.

Original languageEnglish (US)
Pages (from-to)1111-1116
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume9
Issue number11
DOIs
StatePublished - Nov 8 2018

Fingerprint

Influenza A virus
Viruses
Protons
Oseltamivir
Antiviral Agents
Lead compounds
Permeability
Membranes
Virus Replication
Orthomyxoviridae
Human Influenza
Liver
Mutation
Genes
Infection
Pharmaceutical Preparations

Keywords

  • AM2 proton channel
  • AM2-S31N inhibitor
  • antiviral
  • Influenza A virus
  • microsomal stability

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Cite this

Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers. / Hu, Yanmei; Hau, Raymond Kin; Wang, Yuanxiang; Tuohy, Peter; Zhang, Yongtao; Xu, Shuting; Ma, Chunlong; Wang, Jun.

In: ACS Medicinal Chemistry Letters, Vol. 9, No. 11, 08.11.2018, p. 1111-1116.

Research output: Contribution to journalArticle

Hu, Yanmei ; Hau, Raymond Kin ; Wang, Yuanxiang ; Tuohy, Peter ; Zhang, Yongtao ; Xu, Shuting ; Ma, Chunlong ; Wang, Jun. / Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers. In: ACS Medicinal Chemistry Letters. 2018 ; Vol. 9, No. 11. pp. 1111-1116.
@article{b56e56c758504dcd9ab87b6d1415a6b3,
title = "Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers",
abstract = "Majority of current circulating influenza A viruses carry the S31N mutation in their M2 genes, rendering AM2-S31N as a high profile antiviral drug target. With our continuous interest in developing AM2-S31N channel blockers as novel antivirals targeting both oseltamivir-sensitive and -resistant influenza A viruses, we report herein the structure-property relationship studies of AM2-S31N inhibitors. The goal was to identify lead compounds with improved microsomal stability and membrane permeability. Two lead compounds, 10d and 10e, were found to have high mouse and human liver microsomal stability (T1/2 > 145 min) and membrane permeability (>200 nm/s). Both compounds also inhibit both currently circulating oseltamivir-sensitive and -resistant human influenza A viruses (H1N1 and H3N2) with EC50 values ranging from 0.4 to 2.8 μM and a selectivity index of >100. We also showed for the first time that AM2-S31N channel blockers such as 10e inhibited influenza virus replication at both low and high multiply of infection (102-106 pfu/mL) and the inhibition was not cell-type dependent. Overall, these studies have identified two promising lead candidates for further development as antiviral drugs against drug-resistant influenza A viruses.",
keywords = "AM2 proton channel, AM2-S31N inhibitor, antiviral, Influenza A virus, microsomal stability",
author = "Yanmei Hu and Hau, {Raymond Kin} and Yuanxiang Wang and Peter Tuohy and Yongtao Zhang and Shuting Xu and Chunlong Ma and Jun Wang",
year = "2018",
month = "11",
day = "8",
doi = "10.1021/acsmedchemlett.8b00336",
language = "English (US)",
volume = "9",
pages = "1111--1116",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers

AU - Hu, Yanmei

AU - Hau, Raymond Kin

AU - Wang, Yuanxiang

AU - Tuohy, Peter

AU - Zhang, Yongtao

AU - Xu, Shuting

AU - Ma, Chunlong

AU - Wang, Jun

PY - 2018/11/8

Y1 - 2018/11/8

N2 - Majority of current circulating influenza A viruses carry the S31N mutation in their M2 genes, rendering AM2-S31N as a high profile antiviral drug target. With our continuous interest in developing AM2-S31N channel blockers as novel antivirals targeting both oseltamivir-sensitive and -resistant influenza A viruses, we report herein the structure-property relationship studies of AM2-S31N inhibitors. The goal was to identify lead compounds with improved microsomal stability and membrane permeability. Two lead compounds, 10d and 10e, were found to have high mouse and human liver microsomal stability (T1/2 > 145 min) and membrane permeability (>200 nm/s). Both compounds also inhibit both currently circulating oseltamivir-sensitive and -resistant human influenza A viruses (H1N1 and H3N2) with EC50 values ranging from 0.4 to 2.8 μM and a selectivity index of >100. We also showed for the first time that AM2-S31N channel blockers such as 10e inhibited influenza virus replication at both low and high multiply of infection (102-106 pfu/mL) and the inhibition was not cell-type dependent. Overall, these studies have identified two promising lead candidates for further development as antiviral drugs against drug-resistant influenza A viruses.

AB - Majority of current circulating influenza A viruses carry the S31N mutation in their M2 genes, rendering AM2-S31N as a high profile antiviral drug target. With our continuous interest in developing AM2-S31N channel blockers as novel antivirals targeting both oseltamivir-sensitive and -resistant influenza A viruses, we report herein the structure-property relationship studies of AM2-S31N inhibitors. The goal was to identify lead compounds with improved microsomal stability and membrane permeability. Two lead compounds, 10d and 10e, were found to have high mouse and human liver microsomal stability (T1/2 > 145 min) and membrane permeability (>200 nm/s). Both compounds also inhibit both currently circulating oseltamivir-sensitive and -resistant human influenza A viruses (H1N1 and H3N2) with EC50 values ranging from 0.4 to 2.8 μM and a selectivity index of >100. We also showed for the first time that AM2-S31N channel blockers such as 10e inhibited influenza virus replication at both low and high multiply of infection (102-106 pfu/mL) and the inhibition was not cell-type dependent. Overall, these studies have identified two promising lead candidates for further development as antiviral drugs against drug-resistant influenza A viruses.

KW - AM2 proton channel

KW - AM2-S31N inhibitor

KW - antiviral

KW - Influenza A virus

KW - microsomal stability

UR - http://www.scopus.com/inward/record.url?scp=85054663485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054663485&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.8b00336

DO - 10.1021/acsmedchemlett.8b00336

M3 - Article

AN - SCOPUS:85054663485

VL - 9

SP - 1111

EP - 1116

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 11

ER -